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ABSTRACT 
Methyl xanth ines ( MX ) , such as theophyl l ine, are 
commonly used in the treatment o f  recurrent apnea due to 
the ir st imul ant e f fects on the resp iratory cente r . 
structure-act ivity stud ies have demonstrated that 
substitut i on of a l kyl groups on the 3 -pos ition of the 
xanthine nucl eus results in increased bronchod i l ator 
potency , whi l e  subst itut ion on the 1 -po s i t i on is important 
for adenos ine antagon i sm and CNS stimulation . Three 
d i f ferent a l kyl xanth ines were stud ied to determine the 
structura l requi rements for respi ratory st imul at ion . 
Resp iratory rates and volumes were determined in 4 - to 7-
day-old rats us ing a volume d i spl acement body 
p l ethysmograph . Measurements were made be fore and at 5 
minute interva l s  a fter subcutaneous ( s . c . ) inj ect i on o f  
drug . Theophyl l ine (1 , 3 -diMX , 1 0 - 4 0 mg/kg) increased 
minute vent i l ation (VE) in a dose-rel ated mannor by a s  much 
as 4 5% over basel ine . Increases were observed in both 
t idal volume ( VT ) and respiratory rate ( f ) . 1 -MX (2 0 - 4 0 
mg/kg ) increased VE by a lmost 2 0% ,  primarily by increas ing 
f .  3 -MX (10-20 mg/kg ) fa i l ed to produce a s ign i f icant 
change in VE . These data suggest that subst itut i on at the 
1-pos it ion of the xanthine nucl eus is e s s ent i a l  for 
resp iratory stimulation . The e f fect may be furthe r  
enhanced b y  subst itut ion at the 3 -pos it ion . The data 
further suggest that antagon i sm of adenos ine receptors i s  
necessary for alkyl xanth ine-induced resp i ratory stimulation . 
I dedicate thi s  the s i s  to my fami ly . 
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apprec iated over the years . 
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INTRODUCTION 
Neonatal apnea i s  the most common breathing d i sorder 
in newborn infants (Aranda et a l . ,  1 9 8 3 ) . Apnea i s  
usua l ly defined a s  the cessat ion o f  breathing for more than 
2 0  seconds with or without bradycardia (Avery and Fl etcher , 
1 9 7 4 ) .  The inc idence varies inversely with maturity at 
b i rth . Apnea i s  observed in 2 5% o f  neonates we ighing less 
than 2 5 0 0g at b i rth and can be as  h igh as  8 4% in preterm 
neonates we igh ing less than lOOOg at b i rth (Aranda et a l . ,  
1 9 8 3 ) . I n  cases where apne ic ep isodes are not 
spontaneously terminated , breath ing must be initiated 
through externa l stimulation . Hypoxia secondary to apnea 
is a s ign i f i cant cause of bra in damage and death in 
neonates (Kuzemko and Paal a ,  1 9 7 3) . 
The risk of sudden in fant death syndrome (SIDS ) i s  
d i rectly proport ional t o  the number of apne ic ep isodes 
requ i ring resusc itat ive e f forts ( Ke l l y  et a l . ,  1 9 7 8 ) . For 
many years S I DS aroused l ittl e  interest in the med ical 
commun ity because the diagnos i s  could only be made 
postmortem . Al fred Ste inschne ider (as c ited in Naeye , 
1 9 8 0 )  reported prol onged periods o f  apnea during s l eep in 
s everal in fants who became v i ct ims o f  S I DS . Thi s  
observat ion st imul ated research d i rected towards the 
prevent ion of apnea . 
Some research techn iques were a imed at augment ing the 
resp i ratory center and ranged from cutaneous s t imu l a t i on to 
pharmacological stimulat ion (Aranda et a l . ,  1 9 8 3 ) . 
Pharmaco l og ical stimulat ion would seemingly be a more 
des i rabl e  mode o f  treatment s ince cont inuous observat ion of 
an infant with recurrent apnea is nearly impos s ibl e . 
The resp i ratory st imul ant act ions o f  the 
methylxanthines (MX ) have been known for over a century 
(Leven , 1 8 6 8 ) . Vogl (1 9 2 7 ) demonstrated the e f fect iveness 
o f  aminophyl l ine , the ethyl ened iamine salt of theophyl l ine 
( 1 , 3 -d iMX ) , in the treatment of adults with Cheyne-Stokes 
resp i rat i on . In 1 9 7 3 , Kuzemko and Paa l a  found that rectal 
admini strat ion o f  aminophy l l ine reduced the occurrence of 
apnea in preterm in fants . The i r  observat ion has been 
con f i rmed by severa l other groups and extended to include 
ca f fe ine ( 1 , 3 , 7 -triMX ) (Aranda and Turmen , 1 9 7 9 ) . 
Theophy l l ine and caffe ine (F igure 1 )  are now used rout inely 
in the treatment o f  recurrent apnea of prematur ity . 
MXs have been shown to st imulate the resp i ratory 
center o f  premature in fants (Dav i et a l . ,  1 9 7 8 ) . They 
cause an increase in minute vent i l at i on (VE ) '  as wel l  as an 
increased sens itivity of centra l chemoreceptors to co2 . As 
a consequence , the inc idence of apnea is decreased and 
arterial bl ood gases improved . These e f fects appear to be 
med iated at the l eve l of the bra instem (E ldr idge , et a l . 
1 9 8 3 ) . The findings o f  Lundberg et a l . ( 1 9 8 1 )  a l s o  suggest 
a central s ite o f  action , showing theophyl line had l i tt l e  
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e f fect on periphera l chemoreceptor act ivity in rats . 
The MXs have a number o f  actions outs ide o f  
resp iratory stimulation which are of  cl inica l importance . 
Both theophyl l ine and ca f feine cause bronchod i l at ion 
(Persson et al . ,  1 9 8 2 b )  and theophyl l ine i s  widely used in 
the treatment o f  asthma . Minor adverse e ffects include 
d iure s i s  and increased gastric secret i on (Andersson et a l . ,  
1 9 8 0 ) .  More serious adverse e f fects include tachycard i a  and 
central nervous system ( CNS ) stimulation , resulting i n  
i rritab i l ity , insomnia or even convu l s ions ( Aranda and 
Turmen , 1 9 7 9) .  There fore , f ind ing a drug conta ining the 
resp iratory st imul ant propert ies but devo id o f  these 
unde s i rabl e  s ide e f fects i s  o f  great importance .  
The exact mechan i sm by wh ich the e f fects o f  the MX ' s  
are el ic ited i s  not yet known . However , there are act i ons 
that take pl ace at the cel lular l evel wh ich could 
contribute to these pharmaco l ogical act ions . F i rst , 
theophyl l ine i s  an inhib itor of phosphod iesterase , the 
enzyme respons ibl e  for the inact ivat ion of cycl ic 
adenos ine - 3 ' , 5 ' -monophosphate ( cAMP ) ( Butcher and 
Sutherl and , 1 9 6 2 ) . Th is mechan i sm may not be cl inica l ly 
s ign i f i cant because at therapeut ic concentrations thi s  
act ion i s  too weak t o  b e  respons ib l e  for such a n  e f fect a s  
smooth musc l e  rel axat ion ( Kolbeck e t  a l . ,  1 9 7 9 ) . S econdly , 
the MX ' s  increase the permeab i l ity of the sarcop l a smic 
ret iculum wh ich directly increases the concentrat ion of 
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intracel lular Ca++ . However ,  th i s  act ion a l so requ i res 
h igher than norma l therapeut ic concentrat ions (Ra l l, 1 9 8 5 ) . 
Thi rdly , the MX ' s  may antagon ize the e f fects o f  endogenous 
adenos ine at its receptors . Adenos ine interacts with two 
types o f  receptors , des ignated A1 and A2, to produce some 
o f  its e f fects (Da ly , 1 9 8 2 ) . The inhibit ion o f  adenyl ate 
cyclase (AC ) , the enzyme respons ible for the synthes i s  o f  
cAMP , i s  med iated by A1 receptors wh i l e  interact ion o f  
adenosine with A2 receptors causes stimul at ion o f  AC 
(Schwabe et a l . ,  1 9 8 5 ) . Theophyl l ine and several other MXs 
inhibit the b ind ing of various adenosine ana l ogs to both A1 
and A2 type receptors . 
The primary triggering event in the onset o f  apnea may 
be hypoxia (R igatto and Brady , 1 9 7 2 ) . Th i s  cond i t i on 
st imul ates the release o f  adenos ine in the bra in (Winn et 
al . ,  1 9 8 1 )  and endogenous adenos ine- induced resp iratory 
depress ion has been documented (Wes sberg et a l . ,  1 9 8 5 ) . 
Adenos ine ana l ogs have been shown to depress vent i l at ion in 
newborn rabb its (Lagercrantz et a l . ,  1 9 8 4 ) and p i g l ets 
(Kattwinkel and Darne l l , 1 9 8 2 ) . Watt et a l . ( 1 9 8 6 )  have 
shown that adenos ine g iven intravenous ly to neonatal 
rabb its commonly caused a depress ion in resp i rat ion , 
whereas ana l ogous treatments in adult rabb its caused 
resp i ratory stimulation . The source o f  th i s  apparent 
contradict ion may l ie in the bl ood-bra in barrier . I n  adult 
animal s  the blood-brain barrier appears to a l l ow passage of 
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only l imited amounts o f  adenos ine , there fore prevent ing a 
concentrat ion in the bra in su f f ic i ent to cause resp iratory 
depress ion (Berne et a l . ,  1 9 7 4 ) . Hedner and col l aborators 
( 1 9 8 4 ) observed a s ign i f icant decrease in VE in preterm 
rabb its treated with an intraperitonea l inj ect ion o f  the 
stab l e  adenos ine anal og L-N6 -phenyl isopropyl adenos ine (L­
PIA ) .  The maj or cause o f  the reduced vent i l at i on was the 
decrease in resp iratory frequency ( f )  primarily due to the 
prol ongati on of exp i rat ion . 
The ab i l ity o f  theophyl l ine to reverse the e f fects o f  
adenos ine- induced respi ratory depress ion i s  wel l  documented 
(Eldridge et a l . ;  1 9 8 3 , Lagercrantz et a l . 1 9 8 4; Watt et 
al . ,  1 9 8 6 ) . As previously stated , the s ite o f  action seems 
to be centra l ly l ocated s ince the pos s ib i l ity of MXs act ing 
via vaga l re f l exes and/ or carot id body chemoreceptors has 
been repeatedly di sproven (Lundberg et a l . ,  1 9 8 1; Eldridge 
et a l . ,  1 9 8 3 ) . 
A study o f  the structure-activ ity relat ionsh ips (SAR ) 
o f  various xanth ine ana l ogs appears useful in determining 
the i r  relative antagon ism to adenos ine (Figure 2 ) . Bruns 
( 1 9 8 1 )  examined the adenos ine antagon istic ef fects of 8 0  
d i f ferent a l kyl xanth ines . Snyder et a l . ( 1 9 8 1 ) found a 
corre l ation between general CNS stimulation (l ocomotor 
act ivity ) and d i spl acement o f  agon ist b i nding to adenos ine 
A1 receptors in bra in t i s sue in mice for a number of MXs . 
A series o f  1 -substituted theobromine (3 , 7 -d iMX ) analogs 
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were stud ied for resp i ratory stimul ation in anesthet ized 
dogs (Scott et a l . ,  1 9 4 6 ) . The order o f  decreas ing potency 
of these substitut ions was propyl > butyl > ethyl > methyl . 
Persson et a l . ( 1 9 8 5 ) studied the e f fects o f  a series o f  
1 - and 3 -a l kyl xanthine derivat ives o n  tracheal smooth 
musc l e  tone in gu inea pigs . They concluded that 1 -
a l kylxanth ines , a s  wel l  a s  theophyl l ine , exhib ited 
cons istent antagoni sm of adenos ine . A s im i l a r  series o f  3 -
a l kylxanth ines , notably 3 -propyl xanth ine (enprofyl l ine ) , 
were up to s i x  t imes more potent as trachea l  re laxants than 
theophyl l ine , but pract ica l ly devo id of adenos ine 
antagon istic act iv ity 
An understanding o f  the mechan ism o f  act ion and SAR o f  
the xanth ines wi l l  contribute t o  the search for sa fer drugs 
to treat resp i ratory control disorders . It appears that 
antagon ism o f  endogenous adenos ine could p l ay an important 
rol e  in the reversal o f  neonata l apnea . As prev ious l y  
mentioned , 1-alkyl xanth ines have been shown to con s i stently 
antagon ize adenos ine wh i l e  3 -alkyl xanth ines have not . The 
present study was designed to determine whether resp i ratory 
stimulation by MXs was due to occupat ion of the 1 - or the 
3 -pos ition of the xanth ine nucl eus or a comb ination of the 
two . 
The hypothes i s  to be tested i s  that the resp i ratory 
stimu l at i on associated with the drug theophyl l ine i s  ma inly 
due to the methyl subst ituent on the 1 -po s it i on rather than 
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the occupation o f  the 3 -pos ition . Thi s  hypothes i s  was 
tested comparing the resp iratory e f fects of theophyl l ine , 
1 -MX and 3 -MX on newborn rats . 
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METHODS 
Animals. Newborn Sprague-Dawl ey rats (Harlan Sprague­
Dawley , Indianapol i s , IN ) between four and seven days old 
were used in all experiments . The rats were reared in the 
Zool ogy department ' s  an imal care fac i l ities . Each rat was 
used only once . 
Recordings. To measure respi rat i on ( f , VE' and tidal 
volume (VT ) )  the rats were pl aced in a volume d i sp l acement 
pl ethysmograph , s im i l a r  to that used by Mortola ( 1 9 8 4 ) . 
Bri e f ly , it cons isted o f  a hol l ow tube o f  approximately 
40ml in volume , in wh ich the an ima l could rest in the prone 
pos ition with the head emerging from a thin rubber sheath 
a l l owing for free breathing . The area around the neck was 
coated with a water-solubl e lubricant to assure seal ing and 
the other end was plugged with a one-hol e  rubber stopper 
wh ich was connected v i a  tub ing to #0000 F l e i sch Flow 
Transducer (F igure 3 ) . Excurs i ons o f  the chest wal l  
produced f l ows o f  a i r  into and out o f  the cyl inder wh ich 
were measured by the f l ow transducer connected to a 
d i f ferential pres sure transducer (Val idyne model MCl - 3 ) . 
The s igna l was recorded as flow and cumulat ive volume by a 
trac ing on a phys iograph (Narco MK III-S ) . The ana l og 
s igna l taken from the physi ograph was digit ized by a Cyborg 
ISAAC A/ D  interface to be recorded and ana lyzed by an IBM 
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compat ibl e  Zenith computer . Th i s  informat ion was proces sed 
by the program "RES P" written by Dr . K ip L .  McG i l l iard with 
the aid o f  Labsoft so ftware (Cyborg Corp . , Newton , MA ) . A 
typ ical printout from thi s  program i s  reproduced in tab l e  
1 .  The rat ' s  body temperature was ma intained by p l ac ing 
the p l ethysmograph ins ide of a heated water j acket 
ma inta ined at 3 5°c .  
Drugs. Both 3 -methyl xanthine and theophy l l ine were 
purchased f rom S igma Chemical Company (St . Lou i s , MO ) . 
1 -Methylxanth ine was synthes ized a s  described be l ow . 
Synthesis of 1-Methylxanthine. The synthes i s  o f  1 -MX 
was accompl i shed in col l aborat ion with Dr . T .  Howard Bl ack 
of the Chem istry Department (Black and Gatto , 1 9 8 9 ) . 
Methyl i sourea HCl 2 was obta ined by pass ing hydrogen 
chloride gas through a methanol s o lut ion of cyanamide 1 
(Figure 4 ) . The HCl was bubbl ed into the solut ion unt il 
the tota l we ight of the react ion mixture increased equal to 
the mas s  o f  cyanamide used in the react ion (Kurzer and 
Lawson , 1 9 6 3 ) . The cyanamide was extracted with ether , 
from a 50/ 50 mixture in water . The ethereal solution was 
then treated with magnes ium sul fate to a ssure dryness . The 
ether was evaporated , l eaving the cyanamide as a c l ear , 
colorl ess o i l . 
The condensat ion o f  pyrimidine 3 was ach i eved by 
re flux ing 2 and ethyl cyanoacetate in a sod ium 
methoxide/methanol solut ion for 20h . 
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A s lurry o f  pyrimidine 3 in d imethyl formamide , was 
added to a one mol a r  equ ival ent of sodium hydride . The 
start i ng material went into solut ion with the expu l s ion o f  
hydrogen gas . Three equ ival ents o f  trimethyl phosphate 
were added and the mixture sti rred for 1 5h . A white 
precip itate had formed and was determined to be the des i red 
1 -methyl ated product 4. 
Compound 4 was dissolved in hot water with one 
equ iva l ent of sod ium n itrite . Upon the add it i on o f  acetic 
acid the n itroso compound 5 crysta l l ized in a bri l l iant 
purpl e  color . S t i rring 5 in concentrated ammon ium sul f ide 
for lh a f forded the diaminopyrimidine 6. The crude product 
was a l ime green paste wh ich yie lded flu f fy wh ite crysta l s  
a fter recrystal l ization from water . 
Condensat ion to the purine was produced by re f luxing 6 
in formamide for lOh . Th i s  caused a color change f rom 
bright orange to j et bl ack , a l ong with a strong odor of 
ammonia . Once the reaction cooled to room temperature it 
was d i luted with water and set in a re fr igerator overnight . 
After f i ltering the mixture , a bl ack res idue rema ined on 
the f i lter paper wh ich was scraped o f f  and d i s s o lved in 
acidi f i ed water . The solution was treated with 
decoloriz ing carbon and then bo i l ed down to approx imately 
hal f the volume . Upon cool ing with ice the product 7 fell 
out o f  solution . 
Treatments. An initial study o f  the e f fects o f  
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intracerebroventricular (ICV )  inject ions o f  theophy l l ine 
was performed on 3 2  rats us ing a method mod i f ied from Hal ey 
and McCormick ( 1 9 5 7 ) . Th i s  method involved penetrat ion o f  
the scalp , skul l ,  and bra in b y  a 2 7  gauge syringe need l e  to 
a depth of 2 mm .  Three groups o f  e ight rats each were 
administered 5 ul solutions of e ither 5 ,  1 0 , or 1 5mg/ml of 
theophyl l ine di ssolved in 0 . 9% NaCl . The rema ining group 
was used as control , rece iving sal ine only . The inj ect ion 
volume was 5 ul in a l l  cases . 
MX solutions for subcutaneous (s . c . ) admini strat ion 
were d i s s o lved in 0 . 9% NaCl in concentrat i ons ranging from 
2 to 8 mg/ml . The solut ions were prepared in such a manner 
that a l l  rats , including sal ine contro l s , rece ived 
inject ions of 5 ul/g body we ight . The doses o f  
theophy l l ine and 1 -MX were 1 0 , 2 0 , and 4 0  mg/kg body 
we ight . Each rat rece ived approx imately s i x  t imes the 
amount of drug than those injected by the rev method to 
account for metabol ism . Administrat ion of 3 -MX was l imited 
by the solub i l ity of the drug . Rats receiving 1 0  mg/kg 
were injected with 5 ul/g o f  a 2 mg/ml solut i on . Thos e  
receiv ing 20 mg/kg were injected with 1 0  u l / g  o f  the same 
solut i on . S ince l arger inject ion volumes were not 
pract ica l , 3 -MX was not tested at 4 0  mg/kg . 
The anima l s  were pl aced in the p l ethysmograph and 
a l l owed to accl imate for 1 0 - 1 5  minutes be fore taking a 
pre inj ection control measurement . The drugs were then 
1 1  
admini stered s . c . in the scalp without remov ing the anima l 
from the apparatus . Postinject ion readings were taken at 
f ive-minute interva l s  for 60 minutes in order to determ ine 
peak response t ime . Each reading cons i sted o f  the average 
of two representat ive 10-sec respi ratory trac ings (Figure 
5) . E ight rats were used at each dose except for 
theophyll ine in which ten rats were used . Each experiment 
conta ined a control group which was injected with i sotoni c  
s a l ine and exposed to the same condit ions a s  the others . 
Statistics. Data were analyzed by two-way analys i s  o f  
variance (ANOVA) with repeated measures . Th i s  was 
accomp l i shed by the use of NWA Statpack ( Northwest 
Ana lytica l , Inc . , Portl and , OR) so ftware on a Zen ith (IBM 
compatibl e) persona l computer . S impl e  means ana lys i s  was 
used to determine s ign i f icance at each t ime interval 
(Winer , 1 9 6 2) and Tukey ' s  mul t i -compar i s on test was used to 
compare indiv idua l means (Steel and Torrie , 1 9 8 0) .  Sample 
computat ions are shown in Append ix I .  A probab i l ity l evel 
o f  less than 0 . 05 was cons idered to be stat i stical ly 
s ign i f icant . Ind iv idual ANOVA tables may be found i n  
Appendix II . 
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RESULTS 
The predrug basel ine (BL) control values for f ,  VE' 
and VT are summar ized in Tab l e  2 .  Among the 9 6  rats tested 
( s . c .  admin i strat ion ) , the mean ( ±SEM ) f was 15 1 ±2 
breaths/min , VE was 1 6 . 1  + 0 . 5  ml/min , and VT was 0 . 10 6  
±0 . 0 0 2  ml . There was a stat i st ical ly s igni f icant 
d i f ference between predrug contro l s  in one case ( 1-MX , f ) . 
Any d i f ferences present at the beg inning o f  an experiment 
were contro l l ed for by comparing each rat to its own 
pre inject ion control , thus obtain ing a percent change in f ,  
VE' or VT . 
E f fects o f  S a l ine in Newborn Rats . 
I n  a l l  sal ine-admini stered rats ( 0 . 9% NaCl s . c .  or 
I CV )  a gradual decl ine in f ,  VE , and VT was observed with 
t ime ( F igures 6 ,  7, 8 ,  and 9) . 
E f fects o f  Theophyl l ine in Newborn Rats . 
The I CV admini strat ion o f  theophy l l ine ( 5  to 15 mg/ml ) 
did not s ign i f icantly a lter VE ( p  = 0 . 2 4 ,  Figure 9) . Thi s  
prompted the invest igat ion o f  peripheral admini strat ion o f  
theophyl l ine a s  we l l  as 1-MX and 3 -MX . 
Subcutaneous admini strat ion o f  theophyl l ine resul ted 
in an increase in VE above predrug BL control s  by as much 
as 4 0% ( s ign i f icant , p < 0 . 0 1 ) . Beg inning at 3 0  min , a 
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s ign i f icant dose-dependent increase in VE was observed ( p  < 
0 . 0 1) (Figure 7A) which cont inued throughout the 6 0 -min 
study period . The increase in VE could be accounted for by 
increases in both f and VT (Figures 7 B  and 7 C) .  The 
increase in VT was stat istica l ly s ign i f i cant ( p  < 0 . 0 1) .  
However ,  the tendency towards increas ing frequency was not 
stat i s t i ca l l y  s igni f icant (p = 0 . 0 7) . 
E f fects o f  1-Methyl xanth ine in Newborn Rats . 
Admini strat ion o f  1 -MX resulted in a s ign i f icant t ime­
and dose-re l ated increase in VE by as much as 2 0% above 
predrug BL contro l s , primarily due to an increase in f ( p  < 
0 . 0 1) .  A s ign i f icant increase in VE wa s f i rst observed at 
4 0  min postinj ect ion , with a peak at 50 min (Figure SA). 
Whi l e  f was s ign i f icantly increased ( p  < 0 . 0 1) ,  VT was 
unchanged by 1-MX (p = 0 . 9 2) (F igure SC ) .  
E f fects o f  3 -Methyl xanth ine in Newborn Rats 
Admini strat ion of 3 -MX resulted in no s ign i f icant 
change in VE (p = 0 . 2 3 ,  Figure 9A) .  There a l so were no 
s ign i f icant changes in f (p = 0 . 4 9) or VT (p = 0 . 0 6 ,  
Figures 9 B  and 9 C )  . There were no s i gni f i cant changes in 
mean insp iratory f l ow (p  = 0 . 2 2) (VT/T1; T1= t ime of  
insp i rat ion) . 
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DISCUSSION 
Recurrent apnea i s  a l i fe-threatening condit ion which 
i s  espec i a l ly preva l ent in the premature infant . Shannon 
and Kel ly ( 19 8 2) reported that prol onged apnea occurred 
more frequently than norma l in in fants with near-S IDS , some 
of whom consequently d i ed of S IDS . The ab i l ity o f  
theophy l l ine t o  reduce the occurrence and duration o f  
apne i c  spel l s  has been convinc ingly demonstrated (Kuzemko 
and Paal a , 19 7 3; Aranda and Turmen , 1 9 7 7 ) . Presently , 
theophyl l ine i s  used in the treatment o f  many resp iratory 
d i sorders including neonatal apnea . 
Its bene f its include an increase in VE as  wel l  as  a 
decrease in the inc idence o f  apnea , thus improving the 
arterial b l ood gases (Eldr idge et a l . ,  19 8 3) . It is 
necessary to ment ion that unde s i rabl e  s ide e f fects are 
o ften associated with the use of MXs . The maj or s ide 
e f fect is stimulation o f  the CNS , caus ing restles snes s ,  
insomnia , tremors and even convu l s ions in exce s s ive 
concentrat ions (Ra l l , 19 8 5) .  Tachycard ia is a l s o  a common 
comp l icat ion of MX treatment (Davi et a l . ,  19 7 8) . 
The mechanism or mechan i sms responsible for the 
e f fects of theophyl l ine are presently unc l ear . There are 
three cellular act ions which may account for the increased 
resp i ration produced by theophyl l ine administrat ion : 1) 
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the inhibition o f  phosphodiesterase , 2) the increase in 
intrace l lular ca++ , and 3) adenos ine antagoni sm .  The thi rd 
mechan i sm i s  the most accepted s ince the f i rst two requ i re 
l a rger doses than therapeut ica l ly used to st imul ate 
respiration (Ral l ,  19 8 5) .  
I n  19 8 1 ,  Winn and co-workers d i scovered that the bra in 
rel eases adenos ine under conditions of hypox i a . Hypox i a  i s  
a l s o  associated with the onset o f  apnea ( R igatto and Brady , 
19 7 2); consequently , adenosine antagon i sm appears as a 
l ikel y  mechan i sm o f  action for MX-generated resp i ratory 
stimu l at ion during apnea . A recent observat ion by Easton 
and Anthon isen ( 19 8 8) is cons istent with thi s  theory , 
showing a part i a l  a l l eviat ion o f  hypox ia-induced 
vent i l atory decl ine via aminophyl l ine treatment in young 
adults . 
SAR studies o f  the xanthine nucl eus have shown that 
a l kyl occupat ion of the !-pos it ion is nece ssary for 
adeno s i ne antagoni sm ,  with the opt imum e f fect e l i c ited via 
a propyl group ( Pers son et a l . ,  19 8 5) ( F igure 2) whereas 
a l ky l at i on o f  the 3 -pos ition i s  needed to produce 
bronchod i l at ion ( Persson et al . ,  19 8 2 b) .  In a previous 
study Reynolds ( 19 8 7) demonstrated that enpro fyl l ine (3 -
propylxanthine) did not produce resp i ratory s t imu l at ion in 
newborn rats . Wh i l e  1-propyl xanth ine has been ment ioned in 
two previous publ ications ( Persson et a l . 19 8 5; Erj efalt 
and Pers son , 19 8 5) ,  the compound i s  unava i l ab l e  at present . 
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There fore we chose to invest igate three methy l -substituted 
xanthines . It  was the goa l o f  the present study to 
determine if resp iratory stimulation i s  brought about due 
to the methyl group on the 1- or 3 -position of theophyll ine 
in hopes of ident i fying or produc ing a xanthine with 
resp i ratory stimul ant properties but l acking harmful s ide 
e ffects . 
Synthesis of 1-methylxanthine 
As part o f  a program a imed at the devel opment o f  novel 
resp i ratory st imul ant agents , we requ i red a substant i a l  
quant ity o f  1-methylxanth ine . Although it i s  commerc i a l ly 
ava i l abl e , its very h igh cost ( over $2 0 0/gram) prompted us 
to invest igate an e f f ic ient synthe s i s . After a s igni f icant 
and l engthy devel opment e f fort , we have succeeded in 
re fining , and in some instances s igni f icantly mod i fying , a 
sparsely-deta i l ed , SO-year-old German synthes i s  ( Engelmann , 
19 0 9) to a degree where in reproduc ible and qu ite acceptabl e  
y i e l d s  o f  1-MX are obtained . 
D irect N 1-methylation o f  xanth ine i s  imposs ible due to 
compet ition from the other two nitrogen atoms ( Lister , 
19 7 1) .  Thus , construct ion o f  the xanth ine ring system 
subsequent to methylation is necessary . The synthe s i s  o f  
pyrimidine r ings via condensat ion o f  the appropriate urea 
derivative with ethyl cyanoacetate or di ethyl mal onate i s  
the c l a s s i c  approach ( Traube , 1 9 0 0) .  Condensat i on o f  
methyl i sourea HCl with ethyl cyanoacetate in re flux ing 
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sod ium methoxide/methanol for 2 0  hours a f forded pyrimidine 
3 (F igure 4) . Contrary to the original report , th i s  
extended react ion t ime wa s necessary t o  ach i eve acceptabl e  
y i elds . 
The key methylation step , when carried out with 
d imethyl sul fate in aqueous base a s  reported , resulted in a 
d i sappo int i ng 11% yield . Although this reagent i s  widely 
empl oyed for a l kylat ion of both purine and pyrimid ine 
bases , reported y i elds are o ften quite l ow .  The starting 
material could be recyc l ed , but we sought a more e f f i c ient 
procedure for th i s  trans format ion . After dozens o f  
experiments , i t  was determined that trimethyl phosphate 
(Yamauch i and Kinosh ita , 19 7 3) a f forded the h ighest and 
most reproduc ible yields (7 6% with a h igh state of purity) . 
N itrosation o f  4 in acet ic acid a f forded the deep blue 
n i troso derivat ive 5 wh ich , being unstab l e , was immediately 
reduced with a minimal amount of ammon ium sul f ide (Ruttink , 
19 4 6) to g ive the penu l timate , fluf fy-wh ite 4 , 5-diamino 
pyrimidine derivat ive 6 in 6 0% yield a fter recrysta l l iza­
t ion . 
Engelmann compl eted the synthes i s  by react ion o f  6 
with formamide fol l owed by heat ing the resul t i ng s o l id 
amide with a f l ame . However ,  we found that c l osure o f  the 
imidazol e  r ing could be accomp l i shed v i a  re flux ing 6 in 
acidic formamide for 12 hours (Rutt ink , 19 4 6) .  
Furthermore , i f  concentrated hydroch� oric acid was empl oyed 
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as the proton source , the quantity o f  water introduced 
proved su f f i c ient to s imul taneously hydrolyze the enol 
ether funct ional ity ( the orig inal report executed this 
trans formation as an addit iona l , separate step) . 
I n  summary , we have outl ined a reproduc ibl e , e f f ic i ent 
synthes i s  of 1 -MX 7. The overall yield o f  2 0% cannot be 
compared to the original report , wh ich contained no such 
data . However ,  our sequence i s  two steps shorter and 
e ffects the critical methy l ation step in seven t imes the 
y i e l d  of the earl ier method . We are currently attempting 
to adapt th i s  procedure to a variety o f  1 - a l kylxanth ine 
anal ogs . 
Effects of Methylxanthines on Newborn Rat Respiration. 
I n  order to determine the mechan i sm by wh ich 
theophylline stimul ates resp i ration , the two mono­
methyl ated ana l ogs 1- and 3 -methyl xanth ine were empl oyed . 
Persson and associates ( 198 2 a , b , c ,  1 9 8 5 ) have repeatedly 
demonstrated the adenos i ne antagonistic e f fects of various 
a lkylated xanthines in a variety of t i s sues . The i r  
find ings indicate that 1 - subst ituted xanth ines , regardless 
o f  3 -pos it ion occupation , are potent adenos ine antagon i sts . 
On the other hand , 3 -alkyl xanth ines l acking substitution at 
the 1 -pos it ion have v i rtually no antagon istic act iv ity . I f  
adenos ine antagoni sm i s  the mechan i sm by wh ich xanth ines 
st imul ate resp i ration , then 1 -MX should s igni f icantly 
increase resp i ration whi l e  3 -MX woul d  not . 
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We initia l l y  attempted to test thes e  drugs by d i rect 
admini strat ion into the centra l nervous system . However, 
I CV admin i stration had no e f fect on VE at the dosages 
tested ( F igure 8) . These find ings were cons i stent with the 
work of El dr idge et a l . ( 19 8 3) ,  who a l s o  observed no 
respiratory st imulation with I CV administered theophyll ine 
and aminophyl l ine . However ,  they did not ice that 
theophyl l ine ' s  ab i l ity to reverse the resp i ratory 
depressant e f fects o f  L-PIA st i l l  exi sted a fter I CV 
admini strat ion . They concluded that the neurons caus ing 
resp iratory depress ion due to L-PIA were not the same 
neurons that produce the resp iratory response to systemic 
theophyl l ine . The l ack o f  e f fect when theophyl l ine was 
admini stered rev prompted our study o f  the peripheral 
admini strat ion o f  these compounds . 
I n  each o f  the three control studies , s . c .  inj ection 
o f  isotonic sal ine produced a gradua l decl ine in a l l  
aspects o f  resp i ration tested ( VE , f ,  VT; Figure s 6 ,  7, and 
8) . Thi s  phenomenon wa s most l ike ly due to the anima l s  
calming down a fter initia l ly be ing excited b y  inj ect ion and 
p l acement in the p l ethysmograph . However , the pos s i b i l ity 
that the prol onged immob i l izat ion may have caused the 
decl ine cannot be ruled out . The anima l s  were g iven a 1 0  
m i n  accl imatizat ion t ime be fore the predrug control 
measurement was taken . 
Theophyl l ine (40 mg/kg s . c . )  caused a s igni f icant 
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dose-rel ated increase in resp i rat ion . A s igni f icant 
increase in VE was f i rst observed at ten m i nute s  
postinject ion with a peak response at 4 0  min ( Figure 4 A ) . 
VE increased by as much as  4 0% above BL . The l iterature 
varies to some degree about the e f f icacy of theophyl l ine . 
Values have been reported from 15% above BL contro l s  in 
rabb it pups ( Lagercrantz et a l . ,  19 8 4 ) to 7 2% above BL 
contro l s  in anesthet ized cats ( Eldridge et a l . ,  19 8 3 ) . The 
f i ndings of th i s  study certa inly fa l l  with i n  th i s  range . 
A s ign i f icant ( p  < 0 . 0 1 ) increase in VT was observed 
in theophyl l ine treated rats . The e f fect o f  theophyl l ine 
on VT was f irst seen at 15 min post inject ion and cont inued 
throughout the l ength of the study period ( F igure 7 C} • 
The f a i l ure o f  theophyll ine to s ign i f icant ly increase 
the overa l l  respi ratory rate (p = 0 . 0 7 )  i s  puzzl ing . 
However ,  there was a con s i stent trend for f to be e l evated 
above sal ine contro l s , espec i a l l y  at the 4 0  mg/kg dose . 
Cl early there was a greater e f fect on VT than on f .  The 
peak t ime for f was at 3 5  min post inject ion . 
These observat ions confl ict with the findings o f  
Easton and Anthoni sen ( 1 9 8 8 ) where am inophyl l ine ( the 
ethyl enediamine salt of theophyl l ine ) increased f but 
fa i l ed to increase VT in hypoxi c  young adults . S im i l arly , 
Reynolds ( 19 8 7 ) showed a s ign i f icant increa se in VE 
produced by aminophyl l ine admini strat ion in newborn rats , 
primarily due to an increase in f .  
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The d i screpancy between the above-ment ioned studies 
and the present one can poss ibly be exp l a ined by the use o f  
aminophyl l ine vs . theophyl l ine . Ethyl enedi amine i s  known 
to act as a spec i f ic rel eas ing agent o f  the inh i b i tory 
neurotransmitter ¥-aminobutyric acid ( GABA) ( Ll oyd et a l . ,  
19 8 2 ) . GABA i s  typ i c a l l y  associated with a decrease in 
vent i l at i on due to a reduced VT ( Yamada et a l . ,  19 8 1; 
Kneussel et a l . ,  19 8 6 ) . The work o f  Eldridge and 
col l eagues ( 19 8 3 ) supports th i s  theory showing a depress ion 
in VT a fter I CV admini strat ion o f  ethyl ened iamine . On the 
other hand , Ra l l  ( 1 9 8 5 )  described the d i rect st imul ant 
act ion of aminophyl l ine on the resp i ratory center in the 
medul l a  resulting in the increase of both f and VT . 
A s ign i f icant dose-rel ated increase in VE was 
observed a fter treatment with 1-MX ( 10 - 4 0 mg/kg ) . The 
onset of action was delayed compared to that o f  
theophyl l ine with the f i rst e l evat ion appearing a t  4 0  min 
and a peak response at 50 min postinj ection . Th i s  
observation i s  cons istent with the f i ndings o f  Pers son et 
a l . ( 19 8 2 b ) in wh ich theophy l l ine wa s shown to antagonize 
adenos ine four t imes more e f fect ively than 1 -MX . The 
degree of stimulat i on was reduced in compar i son to 
theophyl l ine , with a peak increase in VE of a lmost 2 0% 
above BL contro l s . The increased vent i l at ion was 
predominantly due to an e l evat ion o f f ( F igure SB). 
I nterestingly , there was no change in VT a fter 
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admini strat ion o f  1-MX ( F igure BC). 
As ant ic ipated 3 -MX did not have a s ign i f icant e f fect 
on VE . Likewise , ne ither f nor VT were s ign i f icant l y  
increased b y  admini strat ion o f  3 -MX . However , the data 
appeared to indicate a trend toward increa s ing VT (p = 
0 . 0 6 ) . The pos s ib i l ity o f  an expanded a i r  passageway 
a l l owing for greater insp i ratory flow was cons idered s ince 
the bronchod i l at ing potency of 3 -a l kylxanthines is wel l ­
documented {Lunell e t  a l . ,  1 9 8 3; Perss on e t  a l . ,  19 8 5 ) . 
Thi s  pos s ib i l ity was el iminated when stat i st ical analys i s  
o f  the mean insp iratory flow ( VT/TI ) revea l ed no 
s ign i f icant change due to 3 -MX (p = 0 . 2 2 ) . I t  i s  doubtful 
that thi s  trend toward increa s i ng VT is of phys iological 
s ign i f icance . S ince solub i l ity problems l imited further 
exp l orat ion of 3 -MX , the pos s ib i l ity still exists that an 
increased dosage could produce st imul ation of resp i rat ion . 
Thi s  researcher i s  unaware o f  any previous report on the 
e f fects of 1-MX or 3 -MX on resp iratory control . 
The results o f  the se experiments suggest that 
theophyl l ine- induced resp iratory stimulat ion occurs v i a  
adenos ine antagon ism . Th i s  theory i s  supported by 1-MX's 
ab i l ity to st imulate resp i ration as we l l  a s  3 -MX's 
inab i l ity to perform the same function comb ined with 
pub l i shed reports indicat ing the 1-alkyl xanthines 
antagon ize adenos ine and 3 -alkyl xanth ines do not {Persson 
et al . ,  19 8 5) .  However ,  our data show that occupat ion o f  
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the 3 -pos ition enhances resp i ratory stimu l at ion . S ince 
theophyl l ine is a more potent antagonist of adenos ine than 
1-MX ( Persson et a l . ,  19 8 2 b ) , it is p l au s i b l e  that a non­
polar substituent in the 3 -pos ition helps stabl ize 
theophyl l ine in a con formation such that the 1-pos ition 
more read i l y  inh ib it s  the b ind ing o f  adenos ine . 
I n  summary , both theophy l l ine and 1-MX ( 10 - 4 0 mg/kg) 
induced stimulation in a dose-re lated manner in the newborn 
rat . 3 -MX ( 10 - 2 0 mg/kg) fa i l ed to st imu l ate resp i rat ion . 
The resul ts o f  th i s  project demonstrate the importance o f  
a l kylat i on o f  the 1-pos it ion o n  the xanthine nucl eus i n  
stimulat ing resp iration . The results a l s o  support the 
hypothes i s  that xanthine-induced resp iratory stimulation 
occurs via adenos ine antagon i sm . 
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Tab l e  1 .  Hardcopy o f  data recorded by the program "RESP". 
N= number o f  breaths, VE= minute vent i l a t ion, F= 
resp iratory rate, TI= t ime o f  insp iration, TE= t ime o f  
exp irat ion, and VT= t idal volume . 
pre inj . 1 -MeXanth . 1 0  mg/ kg 
TRIAL # 1  TRIAL # 2  MEAN 
- - - ----- - - - - ----
N = 2 8  2 4  BREATHS 
VE = 2 1 . 4 2 2 0 . 6 7 2 1 . 0 4 ML/MIN 
F = 1 7 1 1 4 9  1 6 0  BREATHS/MIN 
TI  = 0 . 1 2 0  0 . 1 3 8  0 . 1 2 9  SEC 
TE = 0 . 2 3 1  0 . 2 6 5  0 . 2 4 8  SEC 
TTOT = 0 . 3 5 1  0 . 4 0 3  0 . 3 7 7  SEC 
TI/TTOT = 0 . 3 4 3  0 . 3 4 1  0 . 3 4 2  
VT = 0 . 1 2 5  0 . 1 3 9  0 . 1 3 2  ML 
VT/TI 1 .  0 4 1 1 . 0 1 0  1 . 0 2 5  ML/ SEC 
30 
Tab l e  2 .  Mean ( ±SEM ) BL predrug contro l s  for resp i ratory rate ( f ) , 
minute vent i l at ion (VF.), and t idal volume VT for 
the fol l owing treatments: Sal ine , THEO ( 1 0 , 2 0, & 
4 0  mg/ kg s . c . ) ,  1-MX ( 1 0, 2 0, & 4 0  mg/kg s.c.) and 
3 -MX ( 1 0  & 2 0  mg/kg) . 
Treatment n .f v v 
(br/min) (Eil/min) {1;1) 
THEO (sal ine ) 1 0  1 5 8  ±7 1 8 . 1  ±1 . 6 . 1 1 4  ±· 0 0 7  
( 1 0  mg/kg) 1 0  1 4 5 ±6 1 5 . 8  + 1 . 5  . 1 0 9  + . 0 0 7  
II ( 2 0 mg/kg )  1 0  1 4 5 ±5 1 5 . 9  + 1 . 2  . 1 0 9  ± . 0 0 5  
II (4 0 mg/kg) 1 0  1 4 4  ±7 1 5 . 5  ±1 . 3  . 1 0 9  ±· 0 0 7  
1-MX ( sa l ine ) 8 1 6 0  ±12 1 6 . 3 ±2 . 1  . 1 0 1  ± . 0 0 9  
( 1 0 mg/kg )  8 1 7 2  ±8 1 7 . 4  ±1 . 1  . 1 0 2  ± . 0 0 7  
II ( 2 0 mg/kg )  8 1 4 0 ±5 1 4 . 7  ±0 . 8  . 1 0 5  ± . 0 0 4  
II (4 0 mg/ kg )  8 1 4 2 ±6 1 5 . 3  ±1 . 1  . 1 0 8  ±-0 0 5  
3 -MX ( sa l ine ) 8 1 5 8  ±3 1 9 . 7  ±1 . 9  . 1 2 5  ± . 0 1 1  
( 1 0 mg/ kg )  8 1 5 1  ±6 1 4 . 7  ±1 . 6  . 0 9 7  ±· 0 0 9  
(2 0 mg/ kg )  8 1 4 9  ±7 1 2 . 9 ±1 . 6  . 0 8 6  ±-0 0 7  
ALL RATS 9 6  1 5 1  ±2 1 6 . 1  ±0 . 5  . 1 0 6  ±-0 0 2  
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Figure 1 .  Structures o f  ca f fe ine ( #1 ) and theophy l l ine 
( #2 ) .  
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Figure 2 .  Structure o f  xanth ine nucl eus d i sp l aying 
characteristics o f  subst itut ions at various 
s ites ( Persson et a l . ,  1 9 8 2 c ) . 
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Figure 3 .  Diagram o f  rat in body p l ethysmograph ( courtesy 
of Susan M .  Reynolds , 1 9 8 7 ) . 
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Figure 4 .  synthet ic route to 1 -Methyl xanthine . 
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SCHEME 
OMe a I 
NCNH2 H2N-C=NH HCI 
1 2 \ 
b 
0 0 
Me,N· c H,N 
MeOAN NH MeOAN NH 
4 3 \ d 
0 0 
.Me, NO Me , N NH2 N e 
MeOAN MeOAN NH NH2 
.5 6 
a: MeOH, HCl; b: NaOMe, Eto2ccH2CN; c: NaH, (Me0)3PO; 
d: NaNo2, HOAc; e: (NH4)2S; f: HCONH2, .HCl 
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Figure 5 .  Representat ive trac ing o f  newborn rat 
resp irat i on . 
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postinjection (40 min) 
theophylline 
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F igure 6 .  E f fects o f  theophyl l ine (ICV admini strat i on )  on 
minute vent i l at i on in newborn rats. Po ints 
indicate means and bars indicate ±SEM. Legend : 
sal ine= open c i rc l e s , 5 mg/ml= f i l l ed c ircles, 
1 0  mg/ml= open triangl es , 1 5  mg/ml= f i l l ed 
triangles. 
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F igure 7 .  E f fects o f  theophyl l ine on minute vent i l at i on 
( A ) , resp i ratory rate (B), and t idal volume ( C ) . 
Po ints indicate means and bars indicate ±SEM . 
Asterisks indicate means sign i f i cantly di f ferent 
from sal ine controls (*P < 0 . 0 5 Tukey's Test) . 
Legend : sal ine= open c irc les , 10  mg/ kg= filled 
c i rcles , 2 0  mg/kg= open triang l es ,  4 0  mg/ kg= 
f i l l ed triangl es . 
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Figure 8 .  E f fects o f  1-Methyl xanth ine on minute 
vent i l at i on (A ) , respiratory rate ( B), and t ida l 
volume ( C ) . Po ints ind icate means and bars 
indicate ±SEM . Asteri sks ind icate means 
s igni f icantly d i f ferent from sal ine control s  ( *P 
< 0 . 0 5 Tukey ' s  Test ) . Legend : sal ine= open 
c ircl e s , 10 mg/kg= f i l l ed c i rc l e s , 2 0  mg/kg= 
open triangl es , 4 0  mg/ kg= f i l l ed triangl es . 
46 
<U > 
z 
w c.:> z <( :c u 
· �  
-
z 
w (.) z <( :c u 
� 
....... 
6 0  
5 0 - . 
4 0 . . 
3 0 . . 
2 0  . .  
1 0 . . 
0 . 
- 1 0 . .  
- 2 0  
- 3 0 
- . - . 
A 
- 4 0 -l -t-�-1-
3 0  
2 5 - . D 
2 0 -
1 5 - . 
1 0 - . 
5 -
0 - . 
- 5 
- 1 0 . .  
- 1 5 - -
- 2 0 - . 
-4--1-f-I·---. 1-1-1-1-1 - 2 5 -1-5 0 
4 0 · · c 
> 3 0 . . z 
2 0  . .  
1 0 · · I l . · I . 
- 1 : . : 1�1�1�1�1;;t�l�I�i�f >J 
I 
- 2 0 -
- 1- 1-� --+--i-l-I 
0 55 60 
- 3 o - 1-,'Q1 152_'0 2 5 3 0 3 5  4 0 4 5  5 0 5 
M I N U T E S  P O S T l l� J E C T I O N  
4 7  
Figure 9 .  E f fects o f  3 -Methylxanth ine on minute 
vent i l at i on ( A ) , resp i ratory rate ( B), and t idal 
volume (C) . Po ints ind icate means and bars 
ind icate ±SEM . Asteri sks indicate means 
s ign i f icantly d i f ferent from sal ine contro l s  (*P 
< 0 . 0 5 Tukey ' s  Test ) . Legend : sal ine= open 
c i rcles , 1 0  mg/ kg= f i l l ed circles , 2 0  mg/ kg= 
open triangl es . 
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APPENDIX I 
S amp l e  computation o f  s impl e  ma in e f fects ( W iner , 1 9 6 2 ) : 
Var i at ion due to theophy l l ine at 4 0  min postinj ect ion . 
( Sum o f  NaC1 ) 2 + ( S�m o f  1 0  mg/kg )
2 + 2 ( Sum o f  2 0  mg/kg ) - + ( Sum o f  4 0  mg/kg ) ­
n 
S S  . = at 4 0  min 
MS at 4 0  min 
( Sum o f  NaCl . 1 0 . 2 0 , 4 0  mg/ kg) £ 
nr 
= C - 1 9 7 . 7 ) £ + C - 5 8 . 7 ) £ + C 7 2 . 7 l £ + ( 4 4 8 . 3 ) A -
1 0  
( - 1 9 7 . 7  + - 5 8 . 7  + 1 2 . 1  + 4 4 8 . 3 ) A 
4 0  
= 2 4 8 7 8 . 9  - 1 7 4 7 . 7  
= 2 3 1 3 1 . 2 
= SS at™f O min 
= 2 3 1 3 1 . 2  
3 
= 7 7 1 0 . 4  
sswi' th i' n  ce l l = ss + s s  error A error 
= 1 7 5 5 0 7 . 8  + 9 4 4 7 4 . 2  
= 1 1 1 9 8 2 . 0  
MSwithin ce l l  = ssw��iADiyel l 
= 1 1 1 9 8 2 . 0  
4 3 2  
F = 
= 
= 
= 2 5 9 . 2  
MS t . MS a 4 0 min within cel l 
7 7 1 0 . 4 
2 5 9 . 2  
2 9 . 7  
Compared to tabul ated F = 4 . 8  
Conclus ion : There i s  a s ��nffi�aftt d i f ference between 
treatments at 4 0  min (p < . 0 1 ) . 
5 0  
S amp l e  computation o f  Tukey ' s  Mul t icompar i son Test (Steel 
and Torrie ,  1 9 8 0 ) . 
Compari son o f  treatment means at 4 0  min . 
Tukey ' s w0 . 0 1 = qo . 0 1 (3 , 4 3 2 ) x 
Sy 
= 2 5 9 . 2  
1 0  
= 5 . 0 9 
Tukey ' s  w0 • 0 5  
= 3 . 4  x 5 . 0 9 
= 17 . 3  
D i f ferences between mean treatments at 4 0  min . 
1 0  mg/ kg - SAL = -7 . 8  - - 1 9 . 8  = 1 2 . 0  
2 0  mg/ kg - SAL = 7 . 3 - - 1 9 . 8  = 2 7 . 1  
4 0  mg/kg - SAL = 4 4 . 8  - - 19 . 8  = 6 4 . 6  
Conclus ion : Theophy l l ine % change from basel ine control s  
was s ign i f icantly d i f ferent from sal ine a t  2 0  
and 4 0  mg/kg but not at 1 0  mg/kg . 
5 1  
APPENDIX II . ANOVA tab l e s  for a l l  treatments . 
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Two-way ANOVA with repeated measures o f  theophyl l ine (ICV 
admini stration ) dose-rel ated and t ime course experiments on 
minute vent i l at i on in newborn rats . 
***ANOVA TABLE*** 
S ource DF S S  MS F p 
Treatment 3 1 2 9 0 4 . 6 3  4 3 0 1. 5 4 1. 4 8  < 0. 2 4  
Error 2 8  8 0 9 4 8. 1 2  2 8 9 1. 0 0  
T ime 1 1  5 6 6 7. 9 8  5 1 5. 2 7  1. 8 1  < 0. 0 5  
I nteract i on 3 3  5 9 0 1. 7 1 1 7 8. 2 7  0. 6 3  < 0 . 9 5 
Error 3 0 8 8 7 4 6 9. 1 6  2 8 3. 9 9  
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Two-way ANOVA with repeated measures o f  theophy l l ine dose­
response and t ime course experiments on minute vent i l at ion 
i n  newborn rats . 
* * *  ANOVA TABLE * * *  
S ource OF S S  MS F p 
Treatment 3 1 4 2 1 9 1 . 0 0 4 7 3 9 7 . 0 1 9 . 7 2 < . 0 1 
Error 3 6  1 7 5 5 0 7 . 8 0 4 8 7 5 . 2 2 
T ime 1 1  3 0 3 2 . 8 6 2 7 5 . 7 1 1 . 1 6 < . 3 2 
I nteraction 3 3  1 6 1 7 2 . 0 9 4 9 0 . 0 6 2 . 0 5 < . 0 1 
Error 3 9 6  9 4 4 7 4 . 2 0 2 3 8 . 5 7 
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Two-way ANOVA with repeated measures o f  theophyl l ine dose­
response and t ime course experiments on resp iratory rate in 
newborn rats . 
* * *  ANOVA TABLE * * *  
S ource DF S S  MS F p 
Treatment 3 9 4 8 2 . 9 5 3 1 6 0 . 9 8 2 . 6 0 < . 0 7 
Error 3 6  4 3 8 0 5 . 17  1 2 1 6 . 8 1 
T ime 1 1  4 0 3 0 . 7 9 3 6 6 . 4 4 2 . 3 3 < . 0 1 
I nteraction 3 3  4 1 19 . 3 2 1 2 4 . 8 3 . 7 9 < . 7 7 
Error 3 9 6  6 2 2 2 8 . 4 0 1 5 7 . 1 4 
5 5  
Two-way ANOVA with repeated measures o f  theophyl l ine dose­
response and t ime course experiments on t idal volume in 
newborn rats . 
*** ANOVA TABLE *** 
S ource DF S S  MS F p 
Treatment 3 7 7 6 6 4 . 7 8 2 5 8 8 8 . 2 6 7 . 7 5 < . 0 1 
Error 3 6  1 2 0 2 6 2 . 5 0 3 3 4 0 . 6 3 
T ime 1 1  2 8 9 2 . 5 1 2 6 2 . 9 6 1 '. 8 6  < . 0 4 
I nteract ion 3 3  1 1 2 4 0 . 7 1 3 4 0 . 6 3 2 . 4 1 < . 0 1 
Error 3 9 6  5 5 8 9 8 . 7 2 1 4 1 . 1 6 
5 6  
Two-way ANOVA with repeated mea sures o f  1 -Methy l xanthine 
dose-response and t ime course experiments on m inute 
vent i l at i on in newborn rats . 
*** ANOVA TABLE *** 
S ource DF S S  MS F p 
Treatment 3 2 1 8 8 1 . 9 1  7 2 9 3 . 9 7 4 . 8 7 < . 0 1 
Error 2 8  4 1 9 2 9 . 3 4 1 4 9 7 . 4 8 
T ime 1 1  5 9 7 4 . 6 1 5 4 3 . 1 5 2 . 3 3 < . 0 1 
I nteract ion 3 3  6 5 3 4 . 7 1 1 9 8 . 0 2 . 8 5 < . 7 0 
Error 3 0 8 7 1 6 0 3 . 6 5 2 3 2 . 4 8 
5 7  
Two-way ANOVA with repeated measures o f  1 -Methyl -xanth ine 
dose-response and t ime course experiments on resp i ratory 
rate in newborn rats . 
* * *  ANOVA TABLE * * *  
S ource DF S S  _MS F p 
Treatment 3 1 7 6 5 3 . 1 5 5 8 8 4 . 3 8 5 . 2 3 < . 0 1 
Error 2 8  3 1 4 9 2 . 4 0 1 1 2 4 . 7 3 
T ime 1 1  2 3 5 8 . 4 7 2 1 4 . 4 1 2 . 2 0 < . 0 1 
I nteract ion 3 3  4 9 6 8 . 1 3 1 5 0 . 5 5 1 . 5 4 < . 0 3 
Error 3 0 8 3 0 0 2 3 . 5 0 9 7 . 4 8 
58  
Two-way ANOVA with repeated measures o f  1 -MX dose-response 
and t ime course experiments on t idal volume in newborn rats . 
***ANOVA TABLE*** 
S ource DF S S  MS F p 
Treatment 3 1 18 1 . 5 8 3 9 3 . 8 6 0 . 1 6 < 0 . 9 2  
Error 2 8  6 8 8 2 0 . 7 0  2 4 5 7 . 8 8 
T ime 1 1  5 9 2 9 . 4 2 5 3 9 . 0 4 3 . 5 8 < 0 . 0 1 
I nteract ion 3 3  3 5 1 2 . 7 6 1 0 6 . 4 4 0 . 7 1 < 0 . 8 9  
E rror 3 0 8 4 6 3 9 1 . 5 9 1 5 0 . 6 2 
5 9  
Two-way ANOVA with repeated mea sures o f  3 -MX dose-response 
and t ime course experiments on minute vent i l at ion in newborn 
rats . 
* * *ANOVA TABLE * * *  
S ource DF S S  MS F p 
Treatment 2 9 6 1 8 . 4 6 4 8 09 . 2 3 1 . 5 9 < . 2 3 
Error 2 1  6 3 6 8 9 . 9 7 3 0 3 2 . 8 6 
T ime 1 1  4 5 7 3 . 7 8 4 1 5 . 8 0 1 . 8 5 < . 0 5 
I nteract ion 2 2  6 9 7 7 . 2 1 3 17 . 1 5 1 .  4 1  < . 1 1 
Error 2 3 1  5 1 7 9 3 . 7 3 2 2 4 . 2 2 
60 
Two-way ANOVA with repeated measures o f  3 -MX dose-response 
and t ime course experiments on resp i ratory rate in newborn 
rats . 
***ANOVA TABLE*** 
S ource DF S S  MS F p 
Treatment 2 1 5 7 0 . 5 6 7 8 5 . 2 8 0 . 7 5 < . 4 9 
Error 2 1  2 2 1 2 0 . 5 2 1 0 5 3 . 3 6 
T ime 1 1  2 5 7 3 . 7 2 2 3 3 . 9 7 2 . 0 9 < . 0 3 
I nteract ion 2 2  1 3 7 1 . 9 9 6 2 . 3 6 0 . 5 6 < . 9 5 
Error 2 3 1  2 5 8 3 5 . 4 3 1 1 1 . 8 4 
6 1  
Two-way ANOVA with repeated measures o f  3 -MX dose- response 
and t ime course experiments on t idal volume in newborn rats . 
***ANOVA TABLE*** 
Source DF S S  MS F p 
Treatment 2 1 3 4 7 4 . 5 2 6 7 3 7 . 2 6 3 . 3 1 < . 0 6 
Error 2 1  4 2 7 3 2 . 1 2 2 0 3 4 . 8 6 
T ime 1 1  5 5 9 2 . 2 8 5 0 8 . 3 9 2 . 1 5 < . 0 2 
I nteract ion 2 2  8 4 2 9 . 1 7 3 8 3 . 1 4 1 . 6 2 < . 0 4 
Error 2 3 1  5 4 7 0 8 . 7 1 2 3 6 . 8 3 
6 2  
Two-way ANOVA with repeated mea sures o f  3 -MX dose-related 
response and t ime course experiments on the mean inspiratory 
flow in newborn rats . 
***ANOVA TABLE*** 
Source OF S S  MS F p 
Treatment 2 9 9 5 6 . 8 4 4 9 7 8 . 4 2 1 . 7 3 < . 2 1 
Error 2 1  6 0 4 1 0 . 2 3 2 8 7 6 . 6 8 
T ime 1 1  5 5 5 8 . 9 3 5 0 5 . 3 6 2 . 3 5 < . 0 1 
I nteract ion 2 2  1 0 3 9 4 . 9 6 4 7 2 . 5 0 2 . 19 < . 0 1 
Error 2 3 1  4 9 7 3 7 . 0 5 2 1 5 . 3 1 
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